ReviewBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2026

The Role of OX40 Pathway Inhibition as a New Therapeutic Strategy for Atopic Dermatitis.

David Oliveira Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.